Pfizer Launches Phase 3 Trial For Lyme Disease Vaccine
Pfizer announced this week that it had launched the final phase of testing for an experimental vaccine to prevent Lyme disease in people 5 years old and above. Pfizer and its French partner Valneva, will enroll about […]
